Literature DB >> 33520803

Assessing impaired fasting blood glucose criteria for high-risk dysglycaemic populations: an experience from a European population state.

Sarah Cuschieri1, Stephan Grech2.   

Abstract

PURPOSE: Discrepancies exist between international bodies for the diagnosis of impaired fasting glucose (IFG). The aim of this study was to establish the IFG characteristics and evaluate the best diagnostic IFG criteria in a high risk dysglycaemic population.
METHODS: An IFG population (n = 451) was identified from a national representative cross-sectional survey using a fasting blood glucose (FBG) ranging from 5.60 to 6.99 mmol/L. These participants were invited for a follow-up oral glucose tolerance test (OGTT). Both FBG results (health survey & OGTT) were evaluated in relation to different diagnostic IFG criteria (>5.6 mmol/L vs. >6.1 mmol/L) while comparing to the final OGTT glycemic diagnosis.
RESULTS: Out of the total survey population (n = 1861), 24.34% was diagnosed with IFG. Approximately 50% of the IFG's (n = 227) attended for the OGTT. The majority of the IFG population were male with an overweight-obese status. If the FBG cut-off point of 6.1 mmol/L was followed, more than a quarter of the population attending the OGTT would have had a missed dysglycaemic status.
CONCLUSION: High-risk dysglycaemic and body mass populations may establish a more accurate dysglycaemia diagnosis and outcome when following an FBG cut-off point of >5.60 mmol/L for IFG. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Glucose intolerance; Impaired fasting glucose; Malta; Oral glucose tolerance test; Type 2 diabetes

Year:  2020        PMID: 33520803      PMCID: PMC7843756          DOI: 10.1007/s40200-020-00563-8

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  14 in total

Review 1.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018.

Authors: 
Journal:  Diabetes Care       Date:  2018-01       Impact factor: 19.112

Review 2.  The clinical implications of impaired glucose tolerance.

Authors:  K G Alberti
Journal:  Diabet Med       Date:  1996-11       Impact factor: 4.359

Review 3.  Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

Authors:  N Unwin; J Shaw; P Zimmet; K G M M Alberti
Journal:  Diabet Med       Date:  2002-09       Impact factor: 4.359

4.  "Prediabetes": Are There Problems With This Label? Yes, the Label Creates Further Problems!

Authors:  John S Yudkin
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

5.  Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group.

Authors: 
Journal:  BMJ       Date:  1998-08-08

6.  Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.

Authors:  Sergio Valdés; Patricia Botas; Elías Delgado; Francisco Alvarez; Francisco Diaz Cadórniga
Journal:  Metabolism       Date:  2008-03       Impact factor: 8.694

Review 7.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.

Authors: 
Journal:  Diabetes Care       Date:  2020-01       Impact factor: 19.112

8.  The diabesity health economic crisis-the size of the crisis in a European island state following a cross-sectional study.

Authors:  Sarah Cuschieri; Josanne Vassallo; Neville Calleja; Nikolai Pace; Janice Abela; Bader A Ali; Fatemah Abdullah; Elizier Zahra; Julian Mamo
Journal:  Arch Public Health       Date:  2016-12-12

Review 9.  Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.

Authors:  Wilson C Y Yip; Ivana R Sequeira; Lindsay D Plank; Sally D Poppitt
Journal:  Nutrients       Date:  2017-11-22       Impact factor: 5.717

10.  Diabetes, pre-diabetes and their risk factors in Malta: a study profile of national cross-sectional prevalence study.

Authors:  S Cuschieri; J Vassallo; N Calleja; N Pace; J Mamo
Journal:  Glob Health Epidemiol Genom       Date:  2016-11-23
View more
  2 in total

1.  Mapping the burden of diabetes in five small countries in Europe and setting the agenda for health policy and strategic action.

Authors:  Sarah Cuschieri; Elena Pallari; Natasa Terzic; Ala'a Alkerwi; Árún Kristín Sigurðardóttir
Journal:  Health Res Policy Syst       Date:  2021-03-29

2.  Evolution of Combined Impaired Fasting Glucose and Impaired Glucose Tolerance in β-Thalassemia Major: Results in 58 Patients with a Mean 7.7- year Follow-Up.

Authors:  Vincenzo De Sanctis; Shahina Daar; Ashraf T Soliman; Ploutarchos Tzoulis; Mohamed A Yassin; Christos Kattamis
Journal:  Acta Biomed       Date:  2022-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.